insulin-like growth factor 2 mRNA binding protein 3
RGD ID:
1306512
Description:
Predicted to enable N6-methyladenosine-containing RNA binding activity; mRNA 3'-UTR binding activity; and mRNA 5'-UTR binding activity. Predicted to be involved in CRD-mediated mRNA stabilization and nervous system development. Predicted to be located in P-body and cytoplasmic stress granule. Predicted to be active in cytosol and nucleus. Orthologous to human IGF2BP3 (insulin like growth factor 2 mRNA binding protein 3); INTERACTS WITH (+)-schisandrin B; 1-naphthyl isothiocyanate; 17beta-estradiol.
Ab2-255; insulin-like growth factor 2 mRNA-binding protein 3; insulin-like growth factor 2, binding protein 3; LOC312320; RGD1306512; similar to igf2 mRNA-binding protein 3
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of IGF2BP3 mRNA more ...
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of IGF2BP3 mRNA
[bisphenol A co-treated with Fulvestrant] results in decreased methylation of IGF2BP3 gene, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of IGF2BP3 mRNA
[bisphenol F co-treated with Fulvestrant] results in decreased methylation of IGF2BP3 gene, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of IGF2BP3 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of IGF2BP3 mRNA more ...
[Dextran Sulfate co-treated with azomethane] results in increased expression of IGF2BP3 protein, Berberine inhibits the reaction [[Dextran Sulfate co-treated with azomethane] results in increased expression of IGF2BP3 protein]
[bisphenol A co-treated with Fulvestrant] results in decreased methylation of IGF2BP3 gene, [bisphenol F co-treated with Fulvestrant] results in decreased methylation of IGF2BP3 gene
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of IGF2BP3 mRNA more ...
[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of IGF2BP3 mRNA
[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of IGF2BP3 mRNA
